SDS

Evaporation rate
Not available.
Not applicable.
Flammability (solid, gas)
Upper/lower flammability or explosive limits
Flammability limit - lower
(%)
Not available.
Flammability limit - upper
(%)
Not available.
Explosive limit - lower (%)
Not available.
Explosive limit - upper (%)
Not available.
Vapor pressure
Not available.
Vapor density
Not available.
Relative density
Not available.
Solubility(ies)
Soluble in water
Auto-ignition temperature
Not available.
Decomposition temperature
Not available.
Viscosity
Not available.
Other information
Not explosive.
Explosive properties
Not oxidizing.
Oxidizing properties
10. Stability and Reactivity
The product is stable and non-reactive under normal conditions of use, storage and transport.
Reactivity
No dangerous reaction known under conditions of normal use.
Possibility of hazardous
reactions
Stable under recommended storage conditions.
Chemical stability
Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. Do not mix
with other chemicals.
Conditions to avoid
Strong oxidizing agents.
Incompatible materials
May include and are not limited to: Oxides of carbon.
Hazardous decomposition
products
11. Toxicological Information
Information on likely routes of exposure
Inhalation
Prolonged inhalation may be harmful.
Skin contact
Causes skin irritation.
Eye contact
Causes serious eye damage.
Ingestion
May cause stomach distress, nausea or vomiting.
Symptoms related to the
physical, chemical and
toxicological characteristics
Symptoms may include stinging, tearing, redness, swelling, and blurred vision. Permanent eye
damage including blindness could result. Symptoms may include redness, drying, defatting and
cracking of the skin.
Information on toxicological effects
Acute toxicity
See below.
Test Results
Components
Species
Sodium hydroxide (CAS 1310-73-2)
LD50 Not available
Dermal
Acute
LC50 Not available
Inhalation
LD50 Rabbit
Oral
325 mg/kg, ECHA
Sodium hypochlorite (CAS 7681-52-9)
LD50 Rabbit
Dermal
Acute
> 20 g/kg, ECHA
#36098 Issue date 31-March-2023
Page: 4 of 7